Global Antibiotic Resistance Market Research Report 2023: The Key Large Market Opportunities in AMR & Therapeutic Technology Developments
DUBLIN, Jan. 19, 2023 /PRNewswire/ -- ResearchAndMarkets.com has added a new report titled "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type". This report identifies key opportunities in the growing field of antimicrobial resistance, highlighting new technologies and drugs in development. It covers over 100 biotechnology companies and provides five-year market forecasts. Key topics include strategic analysis, the role of diagnostics, and a dynamic overview of market players, alongside insights into therapeutic technology development opportunities. The report aims to empower informed investment decisions based on the latest data.
- Identifies 6 key large market opportunities in antimicrobial resistance.
- Profiles over 100 biotechnology companies and their technologies.
- Includes five-year market forecasts for informed investment decisions.
- Highlights the role of diagnostics in treating infections.
- New antibiotic developments may not keep pace with rising superbug infections.
- Market competition among numerous biotechnology companies could dilute individual market share.
The report has identified the 6 Key Large Opportunities in this space and developed market forecasts.
Antimicrobial Resistance is creating new kinds of infections and "superbugs" that are resistant to current antibiotic medicines. New technologies (and new drugs) are under development to capture this growing market.
The report has looked at the technology picture too, giving you, plain language understanding of the different ways pathogens, and infections, can be treated, including an explanation of the key role diagnostics will play. This is a market with a lot of players, there are over 100 biotechnology companies profiled in the report. The report summarizes what technologies they are using.
Make investment decisions and valuations with confidence using the latest data. The report includes five-year market forecasts.
Key Topics Covered:
1 Market Guides
1.1 Strategic Situation Analysis
1.2 Guide for Executives and Business Development Staff
1.3 Guide for
2 Introduction and Market Definition
2.1 The Growing Threat and Opportunity of Antimicrobial Resistance
2.2 Defining the Opportunity
2.2.1 Revenue Market Size
2.3 Methods and Sources
2.3.1 Authors
2.3.2 Sources
2.4
2.4.1
2.4.2
3 Overview of a Dynamic Market
3.1 Market Players - Roles & Impacts
3.1.1 Drug manufacturers - Larger/pharmaceutical
3.1.2 Drug manufacturers - Generic
3.1.3
3.1.4 In Vitro Diagnostics Industry
3.1.5 Drug Marketing Companies
3.1.6 Biotechnology Companies
3.1.7 Regulatory Bodies
3.2 Understanding Antimicrobial Resistance
3.2.1 What is Antimicrobial Resistance (AMR)
3.2.2 Bacteria and Other Microbes
3.2.3 The History of Antibiotics
3.2.4 The Role of Animal Husbandry
3.2.5 The Implications of Horizontal Transfer
3.2.6 The Threat of AMR
3.
3.4 The Key Role of Diagnostics in AMR
4 The Market Opportunity of AMR
4.1 The Key Large Market Opportunities in AMR
4.1.1 Streptococcus Pneumoniae (DRSP)
4.1.2 Campylobacter (DRC)
4.1.3 Clostridium Difficile (CD)
4.1.4 Staphylococcus aureus (MRSA)
4.1.5 Neisseria gonorrhoeae (DRNG)
4.1.6 Salmonella (DRNTS)
4.2 Therapeutic Technology Development Opportunities
4.2.1 Using Viruses Against Bacteria
4.2.2 Hydrolytic Enzymes Join the Fight
4.2.3 Antibodies
4.2.4 Vaccines
4.2.5 Probiotic Technology
4.2.6 Peptides vs. Pathogens
4.2.7 Mining Obsolete Science
4.2.8 CRISPR Antibiotics
5 Antibiotic Resistance Recent Developments
5.1.1 Recent Developments - Importance and How to Use This Section
5.1.2 Importance of These Developments
5.1.3 How to Use This Section
5.2 AMR Pandemic Overlooked
5.3 New resistance-busting antibiotic combination
5.4
5.5 Antibiotic resistance outwitted by supercomputers
5.6 STIs Reach Record Highs
5.7 New research using nanoparticles to bolster waning antibiotics
5.8 OpGen Receives FDA Clearance for
5.9
5.10 Positive associations between AM use in animals and AMR in humans
5.11 PEW Antibiotic Pipeline Findings
6 Key Biotechnology Companies and Their Technology
6.1 Melinta Therapeutics
6.2 Arsanis
6.3 Phage Technologies S.A
6.4
6.5 Tetraphase Pharmaceuticals
6.6
6.7 Nabriva Therapeutics
6.8
6.9 Nemesis Bioscience
6.10
6.11
6.12 discuva
6.13 SmartPhage.
6.14 AmpliPhi Biosciences
6.15 Pherecydes Pharma
6.16 Micreos
6.17
6.18 Lumavita
6.19 Madam Therapeutics
6.20
6.21
6.22
6.23 Xellia Pharmaceutials
6.24 Paratek Pharmaceuticals
6.25
6.26
6.27 Fixed Phage
6.28 Enanta Pharmaceuticals, Inc.
6.29 Demuris
6.30 Prommune
6.31 Biosergen
6.32 Innovation Pharmaceuticals
6.33 Aviragen Therapeutics
6.34
6.35
6.36
6.37
6.38
6.39 Theravance Biopharma
6.40 Abbvie
6.41
6.42
6.43 Forge Therapeutics
6.44
6.45 Integrated Biotherapeutics
6.46 Hennepin Life Sciences
6.47
6.48 Contrafect Corporation
6.49
6.50 AiCuris
6.51
6.52
6.53 ABAC Therapeutics
6.54 Alaxia SAS
6.55 Antabio S.A.S
6.56
6.57 BioFilm Pharma
6.58
6.59
6.60
6.61
6.62 Deinobiotics/Deinove
6.63 Destiny Pharma plc
6.64 Eligo Bioscience
6.65
6.66
6.67 MaaT Pharma
6.68
6.69 Mutabilis SAS
6.70
6.71
6.72 Nosopharm
6.73
6.74
6.75
6.76
6.77 SetLance srl
6.78
6.79 Vaxdyn
6.80 Vibiosphen
6.81 Bioaster
6.82 Vivexia
6.83
6.84 Absynth Biologics
6.85 Spero Therapeutics
6.86 Merck
6.87 Symphogen
6.88
6.89 Johnson & Johnson (Janssen)
6.90 Pfizer
6.91 Allergan
6.92 GlaxoSmithKline
6.93 Novartis
6.94 Gilead Sciences
6.95 AstraZeneca
6.96 Sanofi
6.97
6.98 Cipla
6.99
6.100 Wockhardt Ltd.
6.101
6.102 MicuRx
6.103
6.104
6.105 Aridis Pharmaceuticals Inc.
6.106 The Therapeutics Race - Summary of Companies Research Areas
7 Global Market Size
7.1 Global Market by Country
7.2 Global Market by Pathogen
7.3 Global Market by Technology
8 Market Sizes by Pathogen
8.1 DRSP Market
8.2 DRC Market
8.3 CD Market
8.4 MRSA Market
8.5 DRNG Market
8.6 DRNTS Market
8.7 Other Pathogen Market
9 Market Sizes by Technology
9.1 Antibiotics Market
9.2 Phage Market
9.3 Pep/
9.4 Antibodies Market
9.5 Vaccine Market
9.6 Other Technology Market
10 The Future of AMR.
11 Appendices
11.1 United States Medicare System: Top Selling Drugs 2011-2015
For more information about this report visit https://www.researchandmarkets.com/r/vbhz4s
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Fax (outside
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-antibiotic-resistance-market-research-report-2023-the-key-large-market-opportunities-in-amr--therapeutic-technology-developments-301725732.html
SOURCE
FAQ
What are the key opportunities identified in the RDHL press release regarding antibiotic resistance?
How many biotechnology companies are profiled in the antibiotic resistance market report?
What does the antibiotic resistance report include regarding market forecasts?
What is the role of diagnostics in the antibiotic resistance market according to the report?